Ralliant Corporation Common Stock
65.53
$
4.71 %
Ralliant Corporation développe, commercialise et vend des médicaments pour le traitement de la douleur aiguë, notamment dans les domaines de la centrále d'analgésie et la prise en charge post-opératoire.
Price history of Ralliant Corporation Common Stock
Price history of Ralliant Corporation Common Stock
Performance & Momentum
6 Months
18.93 %
1 Year
28.80 %
3 Years
28.80 %
5 Years
15.48 %
Similar stocks to Ralliant Corporation Common Stock
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
